Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 12, 2023

SELL
$132.51 - $164.9 $87,986 - $109,493
-664 Reduced 20.49%
2,576 $347,000
Q1 2023

Apr 12, 2023

BUY
$144.61 - $166.54 $3,904 - $4,496
27 Added 0.84%
3,240 $516,000
Q4 2022

Jan 13, 2023

BUY
$138.31 - $165.87 $46,748 - $56,064
338 Added 11.76%
3,213 $0
Q3 2022

Oct 12, 2022

BUY
$134.21 - $153.93 $15,299 - $17,548
114 Added 4.13%
2,875 $386,000
Q2 2022

Jul 13, 2022

BUY
$137.62 - $174.96 $290,515 - $369,340
2,111 Added 324.77%
2,761 $423,000
Q4 2020

Jan 13, 2021

SELL
$80.49 - $108.67 $5.35 Million - $7.23 Million
-66,492 Reduced 99.03%
650 $70,000
Q3 2020

Oct 08, 2020

SELL
$85.91 - $100.83 $64,690 - $75,924
-753 Reduced 1.11%
67,142 $5.88 Million
Q2 2020

Jul 09, 2020

BUY
$73.37 - $98.18 $4.93 Million - $6.6 Million
67,245 Added 10345.38%
67,895 $6.52 Million
Q3 2018

Oct 11, 2018

SELL
$88.91 - $98.84 $8,090 - $8,994
-91 Reduced 12.28%
650 $61,000
Q1 2018

Apr 09, 2018

BUY
$92.01 - $123.21 $7,728 - $10,349
84 Added 12.79%
741 $70,000
Q4 2017

Jan 18, 2018

BUY
$89.56 - $98.21 $626 - $687
7 Added 1.08%
657 $64,000
Q3 2017

Oct 12, 2017

BUY
$69.85 - $89.22 $45,402 - $57,993
650
650 $58,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Contravisory Investment Management, Inc. Portfolio

Follow Contravisory Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Contravisory Investment Management, Inc. with notifications on news.